Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CIPROFLOXACIN Cause Lung neoplasm malignant? 148 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 148 reports of Lung neoplasm malignant have been filed in association with CIPROFLOXACIN (Ciprofloxacin). This represents 0.3% of all adverse event reports for CIPROFLOXACIN.

148
Reports of Lung neoplasm malignant with CIPROFLOXACIN
0.3%
of all CIPROFLOXACIN reports
35
Deaths
99
Hospitalizations

How Dangerous Is Lung neoplasm malignant From CIPROFLOXACIN?

Of the 148 reports, 35 (23.6%) resulted in death, 99 (66.9%) required hospitalization, and 31 (20.9%) were considered life-threatening.

Is Lung neoplasm malignant Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CIPROFLOXACIN. However, 148 reports have been filed with the FAERS database.

What Other Side Effects Does CIPROFLOXACIN Cause?

Drug hypersensitivity (5,266) Arthralgia (3,749) Pain (3,201) Fatigue (3,056) Drug ineffective (2,918) Nausea (2,689) Neuropathy peripheral (2,607) Diarrhoea (2,599) Pain in extremity (2,522) Dyspnoea (2,340)

What Other Drugs Cause Lung neoplasm malignant?

RANITIDINE (15,214) ADALIMUMAB (698) TIOTROPIUM (637) ETANERCEPT (612) METHOTREXATE (522) CLOZAPINE (440) APIXABAN (411) ALBUTEROL (403) INFLIXIMAB (379) BUDESONIDE\FORMOTEROL (353)

Which CIPROFLOXACIN Alternatives Have Lower Lung neoplasm malignant Risk?

CIPROFLOXACIN vs CIPROFLOXACIN\DEXAMETHASONE CIPROFLOXACIN vs CIPROFLOXACIN\FLUOCINOLONE ACETONIDE CIPROFLOXACIN vs CISAPRIDE CIPROFLOXACIN vs CISATRACURIUM CIPROFLOXACIN vs CISPLATIN

Related Pages

CIPROFLOXACIN Full Profile All Lung neoplasm malignant Reports All Drugs Causing Lung neoplasm malignant CIPROFLOXACIN Demographics